{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T20:03:57Z","timestamp":1784577837538,"version":"3.55.0"},"reference-count":83,"publisher":"Weston Medical Publishing","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Disaster Med"],"abstract":"<jats:p>Objective: To provide an overview of the literature on disaster preparedness regarding surge capacity with a particular focus on vulnerable populations during a pandemic.Design: The Disaster Preparedness and Response Committee of the American College of Emergency Physicians addressed the topic of vulnerable populations during a pandemic. A workgroup of nine physicians with academic and\/or disaster deployment experience was formed. A literature review focused on individuals with access and functional needs, also referred to as special healthcare needs (SHCN) or vulnerable individuals, was performed. Search terms included pandemic, public health emergency of international concern (PHEIC), disaster, COVID-19, vulnerable population, individuals with access and functional needs, special health care needs (SHCN), surge capacity, and CMIST (communications, medical care, independence, supervision, and transportation). Search strategies included medical sources such as PubMed, Medline, Google Scholar, ScienceDirect, Scopus, and the Cochrane Database of Systematic Reviews. Reviews were performed by a librarian. In addition, relevant articles from the bibliographies of included studies and more recent articles identified by committee members were included. The workgroup evaluated the literature and identified issues regarding surge capacity occurring during a pandemic that particularly impacted the SHCN population. Potential solutions were identified. Results: Vulnerable individuals are at greater risk during a pandemic than the general population, although potential solutions to mitigate the impact of a pandemic on vulnerable individuals are possible.Conclusions: Although pandemics can have significant adverse effects on the general population, vulnerable individuals have the greatest morbidity and mortality and are at the greatest risk. Efforts are warranted to better address the negative impact of a pandemic, not just for the general population but also for individuals with access and functional needs, and to find solutions that can help mitigate the consequences of a pandemic.<\/jats:p>","DOI":"10.5055\/ajdm.0527","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T19:30:55Z","timestamp":1784575855000},"page":"119-131","source":"Crossref","is-referenced-by-count":0,"title":["Disaster preparedness for vulnerable populations during a pandemic: Part 2: The origins of a pandemic: Emerging infectious diseases, bioterrorism, and laboratory accidents"],"prefix":"10.5055","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2011-8407","authenticated-orcid":false,"given":"Sharon E.","family":"Mace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance J.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Biddinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Bradin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Burdash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanna","family":"Lefort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Noll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell R.","family":"Moriber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Cornelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3008","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"102207","doi-asserted-by":"crossref","unstructured":"Gamage SD, Kralovic SM, Roselle GA: Emerging infectious diseases: Concepts in preparing for and responding to the next microbial threat. In Koenig KL, Schultz CH (eds.): Koenig and Schultz\u2019s Disaster Medicine: Comprehensive Principles and Practice. 2nd ed. New York: Cambridge University Press, 2016: 93-122 (Chapter 8).","DOI":"10.1017\/CBO9781139629317.011"},{"key":"102208","doi-asserted-by":"crossref","unstructured":"McArthur DB: Emerging infectious diseases. Nurs Clin N Am. 2019; 54(2): 297-311. DOI: 10.1016\/j.cnur.2019.02.006.","DOI":"10.1016\/j.cnur.2019.02.006"},{"key":"102209","unstructured":"Levitt A, Messonnier N, Jernigan D, et al.: Emerging and re-emerging infectious disease threats. In Bennett JE, Dolin R, Blaseer MJ (eds.): Mandell, Douglas and Bennett\u2019s Principles and Practice of Infectious Diseases. 9th ed. Philadelphia, PA: Elsevier, 2020: 164-180 (Chapter 14)."},{"key":"102210","unstructured":"Lipkin WI: Zoonoses. In Bennett JE, Dolin R, Blaser MJ (eds.): Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases. 9th ed. Philadelphia, PA: Elsevier, 2020: 3813-3817 (Chapter 317)."},{"key":"102211","doi-asserted-by":"crossref","unstructured":"Messacar K, Schreiner TL, VanHaren K, et al.: Acute flaccid myelitis: A clinical review of US cases 2012-2015. Ann Neurol. 2016; 80(3): 326-338. DOI: 10.1002\/ana.24730.","DOI":"10.1002\/ana.24730"},{"key":"102212","doi-asserted-by":"crossref","unstructured":"Levi T, Kilpatrick AM, Mangel M, et al.: Deer, predators, and the emergence of Lyme disease. Proc Natl Acad Sci U S A. 2012; 109(27): 10942-10947. DOI: 10.1073\/pnas.1204536109.","DOI":"10.1073\/pnas.1204536109"},{"key":"102213","doi-asserted-by":"crossref","unstructured":"Tazerji SS, Nardini R, Safdar M, et al.: An overview of anthropogenic actions as drivers for emerging and re-emerging zoonotic diseases. Pathogens. 2022; 11(11): 1376. DOI: 10.3390\/pathogens11111376.","DOI":"10.3390\/pathogens11111376"},{"key":"102214","unstructured":"Beard CB, Benesch T, Bente D, et al.: Climate change and infectious diseases. National Emerging Special Pathogens Training & Education Center (NETEC). 2024. Available at https:\/\/netec.org\/2024\/03\/25\/climate-change-and-infectious-diseases\/. Accessed February 20, 2026."},{"key":"102215","doi-asserted-by":"crossref","unstructured":"Rupasinghe R, Chomel BB, Martinez-Lopez B: Climate change and zoonoses: A review of the current status, knowledge gaps, and future trends. Acta Trop. 2022; 226: 106225. DOI: 10.1016\/j.actatropica.2021.106225.","DOI":"10.1016\/j.actatropica.2021.106225"},{"key":"102216","doi-asserted-by":"crossref","unstructured":"Kappler S, Wiesner L, Davis S: Pandemic preparedness and response. In Ciottone GR (ed.): Ciottone\u2019s Disaster Medicine. 3rd ed. Philadelphia, PA: Elsevier, 2024: 36-42 (Chapter 6).","DOI":"10.1016\/B978-0-323-80932-0.00006-9"},{"key":"102217","doi-asserted-by":"crossref","unstructured":"Weiss RA, Sankaran N: Emergence of epidemic diseases: Zoonoses and other origins. Fac Rev. 2022; 11(2). DOI: 10.12703\/r\/11-2.eCollection 2022.","DOI":"10.12703\/r\/11-2"},{"key":"102218","doi-asserted-by":"crossref","unstructured":"Simkin RD, Han BA, Radeloff VC, et al.: Zoonotic host richness in the global wildland-urban interface. Glob Chang Biol. 2025; 31(2). DOI: 10.1111\/gcb.70039.","DOI":"10.1111\/gcb.70039"},{"key":"102219","doi-asserted-by":"crossref","unstructured":"Baker RE, Mahmud AS, Miller IF, et al.: Infectious disease in an era of global change. Nat Rev Microbiol. 2022; 20(4): 193-205. DOI: 10.1038\/s41579-021-00639-z.","DOI":"10.1038\/s41579-021-00639-z"},{"key":"102220","doi-asserted-by":"crossref","unstructured":"Jones KE, Patel NG, Levy MA, et al.: Global trends in emerging infectious diseases. Nature. 2008; 451: 990-993. DOI: 10.1038\/nature06536.","DOI":"10.1038\/nature06536"},{"key":"102221","doi-asserted-by":"crossref","unstructured":"Arthur RR, Leduc JW, Hughes JM, et al.: Surveillance for emerging infectious diseases and bioterrorism threats. In Guerrant RL, Walker DH, Weller PF (eds.): Tropical Infectious Diseases. 2nd ed. Philadelphia, PA: Elsevier, 2006: 195-200 (Chapter 15). DOI: 10.1016\/B978-0-443-06668-9.50020-X.","DOI":"10.1016\/B978-0-443-06668-9.50020-X"},{"key":"102222","doi-asserted-by":"crossref","unstructured":"The Lancet Infectious Diseases (Editorial): Twin threats: Climate change and zoonoses. Lancet Infect Dis. 2023; 23(1): 1.","DOI":"10.1016\/S1473-3099(22)00817-9"},{"key":"102223","doi-asserted-by":"crossref","unstructured":"Van Doom HR: The epidemiology of emerging infectious diseases and pandemics. Medicine (Abingdon). 2021; 49(10): 659-662. DOI: 10.1016\/j.mpmed.2021.07.011.","DOI":"10.1016\/j.mpmed.2021.07.011"},{"key":"102224","doi-asserted-by":"crossref","unstructured":"Zucker JR, Rosen JB, Iwamoto M, et al.: Consequences of undervaccination\u2014Measles outbreak, New York City, 2018-2019. N Engl J Med. 2020; 382(11): 1009-1017. DOI: 10.1056\/NEJMoa1912514.","DOI":"10.1056\/NEJMoa1912514"},{"key":"102225","doi-asserted-by":"crossref","unstructured":"Mathis AD, Raines K, Wiley N, et al.: Measles update\u2014United States, January 1-April 17, 2025. MMWR Morb Mortal Wkly Rep. 2025; 74(14): 232-238.","DOI":"10.15585\/mmwr.mm7414a1"},{"key":"102226","unstructured":"MacDonald E: Texas measles outbreak adds 17 new cases, increasing total to 663. Houston Chronicle. April 29, 2025. Available at htpps:\/\/Texas measles outbreak grows to 663 cases. Accessed May 15, 2025."},{"key":"102227","doi-asserted-by":"crossref","unstructured":"Kiang MV, Bubar KM, Maldonado Y, et al.: Modeling reemergence of vaccine-eliminated infectious diseases under declining vaccination in the US. JAMA. 2025; 333(24): 2176-2187. DOI: 10.1001\/jama.2025.6495.","DOI":"10.1001\/jama.2025.6495"},{"key":"102228","doi-asserted-by":"crossref","unstructured":"Al-Tawfig JA, Azhar EI, Memish ZA, et al.: Middle East respiratory syndrome coronavirus. Semin Respir Crit Care Med. 2021; 42(6): 828-838. DOI: 10.1055\/s-0041-1733804.","DOI":"10.1055\/s-0041-1733804"},{"key":"102229","unstructured":"CDC: About Middle East respiratory syndrome (MERS). 2024. Available at htpps:\/\/About Middle East Respiratory Syndrome (MERS) | MERS | CDC. Accessed 23, 2025."},{"key":"102230","doi-asserted-by":"crossref","unstructured":"Shehata MM, Gomaa MR, Ali MA, et al.: Middle East respiratory syndrome coronavirus: A comprehensive review. Front Med. 2016; 10(2): 120-136. DOI: 10.1007\/s11684-016-0430-6.","DOI":"10.1007\/s11684-016-0430-6"},{"key":"102231","doi-asserted-by":"crossref","unstructured":"Al-Tawfig JA, Al Johani S, Memish ZA: Mers-CoV remains a persistent threat amid global events. J Infect Public Health. 2024; 17(8): 102487. DOI: 10.1016\/j.jiph.2024.102487.","DOI":"10.1016\/j.jiph.2024.102487"},{"key":"102232","unstructured":"Middle East Respiratory Syndrome Coronavirus (MERSCoV) WHO MERS-CoV Global Summary and Risk Assessment: 2016. WHO\/MERS\/RA\/16.1. Available at https:\/\/www.who.int\/docs\/default-source\/documents\/health-topics\/mers\/mers-summary-5december2016.pdf. Accessed February 20, 2026."},{"key":"102233","doi-asserted-by":"crossref","unstructured":"O\u2019Hagan JJ, Carias C, Rudd JM, et al.: Estimation of severe Middle East respiratory syndrome cases in the Middle East, 2012\u20132016. Emerg Infect Dis. 2016; 22(10): 1797-1799. DOI: 10.3201\/eid2210.151121.","DOI":"10.3201\/2210.151121"},{"key":"102234","unstructured":"Flo I, Preston SS: COVID deaths may be underestimated by 36%. Penn health sciences. University of Pennsylvania Today. October 20, 2020. Available at htpps:\/\/U.S. COVID deaths may be underestimated by 36% | Penn Today. Accessed December 8, 2025."},{"key":"102235","doi-asserted-by":"crossref","unstructured":"Kung S, Doppen M, Black M, et al.: Underestimation of COVID-19 mortality during the pandemic. ERJ Open Res. 2021; 7: 00766-2020-2020. DOI: 10.1183\/23120541.00766-2020.","DOI":"10.1183\/23120541.00766-2020"},{"key":"102236","unstructured":"Centers for Disease Control and Prevention (CDC): Bioterrorism agents\/diseases (by category). Emergency preparedness and response. Available at https:\/\/www.bt.cdc.gov\/agent\/agentlistcategory.asp. Accessed May 2, 2025."},{"key":"102237","unstructured":"CDC: Ebola viral hemorrhagic fever. Outbreak history. Available at https:\/\/www.cdc.gov\/ebola\/outbreaks\/index.html. Accessed December 8, 2025."},{"key":"102238","doi-asserted-by":"crossref","unstructured":"Uddin N, Acter T: An overview of global epidemics and the challenges faced. In Jain S, Gruenwald L, Groppe DS (eds.): Leveraging Artificial Intelligence in Global Epidemics. 1st ed. London, UK: Academic Press (Elsevier), 2021: 1-27 (Chapter 1).","DOI":"10.1016\/B978-0-323-89777-8.00011-7"},{"key":"102239","unstructured":"WHO: Ebola West Africa, March 2014-2016. Available at https:\/\/www.who.int\/emergencies\/situations\/ebola-outbreak-2014-2016-West-Africa. Accessed December 8, 2025."},{"key":"102240","unstructured":"CDC: CDC\u2019S response to the 2014-2016 Ebola epidemic\u2014West Africa and the United States. MMWR Morb Mortal Wkly Rep. 2016; 65(Suppl. 3): 1-106."},{"key":"102241","unstructured":"World Health Organization: Pakistan and Afghanistan: The final wild poliovirus bastion. 2019. Available at htps:\/\/Pakistan andAfghanistan: The final wild poliovirus bastion. Accessed December 8, 2025."},{"key":"102242","doi-asserted-by":"crossref","unstructured":"Kayi I, Sakarya S: Policy analysis of suppression and mitigation strategies in the management of an outbreak through the example of COVID-19 pandemic. Infect Dis Clin Microbiol. 2020; 2(1): 30-41.","DOI":"10.36519\/idcm.2020.0009"},{"key":"102243","doi-asserted-by":"crossref","unstructured":"Wu S, Neill R, Foo CD, et al.: Aggressive containment, suppression, and mitigation of COVID-19: Lessons learnt from eight countries. BMJ. 2021; 375: E067508. DOI: 10.1136\/bmj-2021-067508.","DOI":"10.1136\/bmj-2021-067508"},{"key":"102244","doi-asserted-by":"crossref","unstructured":"Parodi SM, Liu VX: From containment to mitigation of COVID-19 in the US. JAMA. 2020; 323(15): 1441-1442.","DOI":"10.1001\/jama.2020.3882"},{"key":"102245","unstructured":"Gostin LO, Berkman BE: Preparing for pandemic influenza: Legal and ethical challenges. In Lemon SM, Hamburg MA, Sparling PF, et al. (eds.): Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary. Institute of Medicine of the National Academies. Strategies for Disease Containment. Washington, DC: The National Academies Press, 2007: 78-90 (Chapter 3)."},{"key":"102246","doi-asserted-by":"crossref","unstructured":"Omar RF, Trottier S, Sato S, et al.: Advances in the management of infectious diseases. Infect Dis Rep. 2025; 17(26): 26-25.","DOI":"10.3390\/idr17020026"},{"key":"102247","doi-asserted-by":"crossref","unstructured":"Fauci AS, Folkers GK: Pandemic preparedness and response: Lessons learned from COVID-19. J Infect Dis. 2023; 228: 422-425.","DOI":"10.1093\/infdis\/jiad095"},{"key":"102248","doi-asserted-by":"crossref","unstructured":"Baraitser L, Salisbury L: \u2018Containment, delay, mitigation\u2019: Waiting and care in the time of a pandemic. Wellcome Open Res. 2020; 5(29): 129-116.","DOI":"10.12688\/wellcomeopenres.15970.1"},{"key":"102249","doi-asserted-by":"crossref","unstructured":"Ellwanger JH, da Veiga ABG, de Lima Kaminski V, et al.: Control and prevention of infectious diseases from a one health perspective. Genet Mol Biol. 2021; 44(1 Suppl. 1): E20200256. DOI: 10.1590\/1678-4685-GMB-2020-0256.","DOI":"10.1590\/1678-4685-gmb-2020-0256"},{"key":"102250","doi-asserted-by":"crossref","unstructured":"Cornelius AP, Mace SE, Char DM, et al.: Disparities in disaster healthcare: A review through a pandemic lens. Am J Disaster Med. 2024; 19(3): 251-263. DOI: 10.5055\/ajdm.0482.","DOI":"10.5055\/ajdm.0482"},{"key":"102251","doi-asserted-by":"crossref","unstructured":"Cornelius AP, Char DM, Ista LG, et al.: Disaster healthcare disparities solutions: Part 2\u2014Response. Am J Disaster Med. 2024; 19(2): 101-108. DOI: 10.5055\/ajdm.0473.","DOI":"10.5055\/ajdm.0473"},{"key":"102252","doi-asserted-by":"crossref","unstructured":"Clouston SAP, Hanes DW, Link BG: Social inequalities and the early provision and dispersal of COVID-19 vaccinations in the United States: A population trends study. Vaccine. 2023; 41(36): 5322-5329. DOI: 10.1016\/j.vaccine.2023.07.022.","DOI":"10.1016\/j.vaccine.2023.07.022"},{"key":"102253","doi-asserted-by":"crossref","unstructured":"Duroseau B, Kipshidze N, Limaye RJ: The impact of delayed access to COVID-19 vaccines in low- and lower-middle income countries. Front Public Health. 2023; 10: 1087138. DOI: 10.3389\/fpubh.2022.1087138.","DOI":"10.3389\/fpubh.2022.1087138"},{"key":"102254","doi-asserted-by":"crossref","unstructured":"Dagovetz M, Momchilov K, Blank L, et al.: Global COVID-19 vaccination challenges: Inequity of access and vaccine hesitancy. J Med Surg Public Health. 2025; 6: 100197.","DOI":"10.1016\/j.glmedi.2025.100197"},{"key":"102255","unstructured":"CDC: Estimates of vaccine hesitancy for COVID-19. Available at https:\/\/data.cdc.gov\/stories\/s\/Vaccine-Hesitancy-for-COVID-19\/cnd2-a6zw. Accessed December 8, 2025."},{"key":"102256","doi-asserted-by":"crossref","unstructured":"Mathieu E, Ritchie H, Ortiz-Ospina E, et al.: A global database of COVID-19 vaccinations. Nat Hum Behav. 2021; 5: 947-953. DOI: 10.1038\/s41562-021-01122-8. Available at https:\/\/www.nature.com\/articles\/s41562-021-01122-8#citeas. Accessed December 8, 2025.","DOI":"10.1038\/s41562-021-01122-8"},{"key":"102257","doi-asserted-by":"crossref","unstructured":"Galagali PM, Kinikar AA, Kumar VS: Vaccine hesitancy: Obstacles and challenges. Curr Pediatr Rep. 2022; 10: 241-248.","DOI":"10.1007\/s40124-022-00278-9"},{"key":"102258","doi-asserted-by":"crossref","unstructured":"Nuwanda RF, Ramzam I, Weekes L, et al.: Vaccine hesitancy: Contemporary issues and historical background. Vaccines. 2022; 10: 1595.","DOI":"10.3390\/vaccines10101595"},{"key":"102259","doi-asserted-by":"crossref","unstructured":"Goje O, Kapoor A: Meeting the challenge of vaccine hesitancy. Cleve Clin J Med. 2024; 91(Suppl. 1): S50-S56.","DOI":"10.3949\/ccjm.91.s1.08"},{"key":"102260","doi-asserted-by":"crossref","unstructured":"Choi Y, Fox AM: Mistrust in public health institutions is a stronger predictor of vaccine hesitancy and uptake than trust in trump. Soc Sci Med. 2022; 314: 115440.","DOI":"10.1016\/j.socscimed.2022.115440"},{"key":"102261","doi-asserted-by":"crossref","unstructured":"Sasse K, Mahabir R, Gkountouna O, et al.: Understanding the determinants of vaccine hesitancy in the United States: A comparison of social surveys and social media. Plos One. 2024; 19: E0301488. DOI: 10.1371\/journal.pone.0301488.","DOI":"10.1371\/journal.pone.0301488"},{"key":"102262","doi-asserted-by":"crossref","unstructured":"Haeder SF: Assessing past and future COVID-19 vaccine hesitancy in the United States in light of federal policy changes. Health Aff Sch. 2023; 1(6): 1-8.","DOI":"10.1093\/haschl\/qxad073"},{"key":"102263","doi-asserted-by":"crossref","unstructured":"Shah GH, Nguyen TH: Vaccine hesitancy through a global lens: Cross-cultural evidence from a special issue. Vaccines. 2025; 13: 529. DOI: 10.3390\/vaccines13050529.","DOI":"10.3390\/vaccines13050529"},{"key":"102264","doi-asserted-by":"crossref","unstructured":"Cooper CA: Vaccine hesitancy and respect for public health measures: Citizens\u2019 trust in politicians and public servants across national, subnational and municipal levels of government. SSM-Population Health. 2023; 22: 101386. DOI: 10.1016\/j.ssmph.2023.101386.","DOI":"10.1016\/j.ssmph.2023.101386"},{"key":"102265","unstructured":"CDC: Vaccination uptake, intent, and confidence. 2025. Available at https:\/\/www.cdc.gov\/respvaxview\/dashboards\/vaccination-behavioral-social-drivers.html. Accessed February 20, 2026."},{"key":"102266","doi-asserted-by":"crossref","unstructured":"Wilson RJ, Paterson P, Jarrett C, et al.: Understanding factors influencing vaccination acceptance during pregnancy globally: A literature review. Vaccine. 2015; 33: 6420-6429.","DOI":"10.1016\/j.vaccine.2015.08.046"},{"key":"102267","doi-asserted-by":"crossref","unstructured":"Gianfredi V, Berti A, Stefanizzi P, et al.: COVID-19 vaccine knowledge, attitude, acceptance and hesitancy among pregnancy and breastfeeding: Systematic review of hospital-based studies. Vaccines. 2023; 11: 1697. DOI: 10.3390\/vaccines11111697.","DOI":"10.3390\/vaccines11111697"},{"key":"102268","doi-asserted-by":"crossref","unstructured":"Dinga JN, Kabakama S, Njimoh DL, et al.: Quantitative synthesis of factors associated with COVID-19 vaccine acceptance and vaccine hesitancy in 185 countries. Vaccines (Basel). 2023; 12: 34. DOI: 10.3390\/vaccines12010034.","DOI":"10.3390\/vaccines12010034"},{"key":"102269","doi-asserted-by":"crossref","unstructured":"Carpiano RM, Callaghan T, DiResta R, et al.: Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era. Lancet. 2023; 401(10380): 967-970. DOI: 10.1016\/S0140-6736(23)00136-8.","DOI":"10.1016\/S0140-6736(23)00136-8"},{"key":"102270","doi-asserted-by":"crossref","unstructured":"Maxwell MJ, Lederman MM: Compulsory immunization protects against infection: What can society and law do? Pathog Immun. 2020; 5(1): 1-7. DOI: 10.20411\/pai.v5i1.344.","DOI":"10.20411\/pai.v5i1.344"},{"key":"102271","doi-asserted-by":"crossref","unstructured":"Puttock EJ, Marquez J, Young DR, et al.: Association of masking policies with mask adherence and distancing during the SARSCOV-2 pandemic. Am J Infect Control. 2022; 50: 969-974.","DOI":"10.1016\/j.ajic.2022.04.010"},{"key":"102272","doi-asserted-by":"crossref","unstructured":"Abaluck J, Kwong LH, Styczynski A, et al.: Impact of community masking on COVID-19: A cluster-randomized trial in Bangladesh. Bangladesh study. Science. 2022; 375: Eabi9069.","DOI":"10.1126\/science.abi9069"},{"key":"102273","doi-asserted-by":"crossref","unstructured":"Floyd CJ, Joachim GE, Boulton ML, et al.: COVID-19 vaccination and mask wearing behaviors in the United States, August 2020-June 2021. Expert Rev Vaccines. 2022; 21(10): 1487-1493. DOI: 10.1080\/14760584.2022.2104251.","DOI":"10.1080\/14760584.2022.2104251"},{"key":"102274","doi-asserted-by":"crossref","unstructured":"Fischer CB, Adrien N, Silguero JJ, et al.: Mask adherence and rate of COVID-19 across the United States. PLoS One. 2021; 16: E0249891. DOI: 10.1371\/journal.pone.0249891.","DOI":"10.1371\/journal.pone.0249891"},{"key":"102275","doi-asserted-by":"crossref","unstructured":"Chen C, Zhou W, Qi J, et al.: Adherence to mask-wearing and its impact on the incidence and deaths of viral respiratory infectious diseases: A systematic review, meta-analysis and modelling study. BMJ Glob Health. 2025; 10: E017087. DOI: 10.1136\/bmjgh-2024-017087.","DOI":"10.1136\/bmjgh-2024-017087"},{"key":"102276","doi-asserted-by":"crossref","unstructured":"Artenstein AW, Haessler S, Burkle A-A, Jr, et al.: Biological attack. In Ciottone GR (eds.): Ciottone\u2019s Disaster Medicine. 3rd ed. Philadelphia, PA: Elsevier, 2024: 511-519 (Chapter 82).","DOI":"10.1016\/B978-0-323-80932-0.00082-3"},{"key":"102277","unstructured":"Suyama J: Bioterrorism. In Tintinalli JE, Ma OJ, Yealy DM, et al. (eds.): Tintinalli\u2019s Emergency Medicine: A Comprehensive Study Guide. 9th ed. New York: McGraw Hill, 2020: 41-46 (Chapter 9)."},{"key":"102278","doi-asserted-by":"crossref","unstructured":"Borio LL, Henderson DA, Hynes NA: Bioterrorism: An overview. In Bennett JE, Dolin R, Blaseer MJ (eds.): Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases. 9th ed. Amsterdam, Netherlands: Elsevier, 2020: 178-190 (Chapter 15).","DOI":"10.1016\/B978-1-4557-4801-3.00015-1"},{"key":"102279","doi-asserted-by":"crossref","unstructured":"Jernigan DB, Raghunathan PL, Bell BP, et al.: Investigation of bioterrorism-related anthrax, United States, 2001: Epidemiological findings. Emerg Infect Dis. 2002; 8(10): 1019-1028. DOI: 10.3201\/eid0810.020353.","DOI":"10.3201\/eid0810.020353"},{"key":"102280","doi-asserted-by":"crossref","unstructured":"Green S, LeDuc J, Cohen D, et al.: Confronting the threat of bioterrorism and defensive strategies. Lancet Infect Dis. 2019; 19(1): e2-e13. DOI: 10.1016\/S1473-3099(18)30298-6.","DOI":"10.1016\/S1473-3099(18)30298-6"},{"key":"102281","doi-asserted-by":"crossref","unstructured":"Dembek ZF, Cieslak TJ: Biological events. In Koenig KL, Schultz CH (eds.): Koenig and Schultz\u2019s Disaster Medicine: Comprehensive Principles and Practice. 2nd ed. New York: Cambridge University Press, 2016: 522-543 (Chapter 32).","DOI":"10.1017\/CBO9781139629317.035"},{"key":"102282","doi-asserted-by":"crossref","unstructured":"Sharma A, Gupta G, Ahmad T, et al.: Next generation agents (synthetic agents): Emerging threats and challenges in detection, protection, and decontamination. In Flora SJS, Pachauri V (eds.): Handbook on Biological Warfare Preparedness. Philadelphia, PA: Elsevier, 2019: 217-256 (Chapter 12).","DOI":"10.1016\/B978-0-12-812026-2.00012-8"},{"key":"102283","doi-asserted-by":"crossref","unstructured":"Jaskiewicz J, Wolf SM, Toner M, et al.: Biopreserving pathogens: Promise and peril. J Law Med Ethics. 2024; 52(3): 624-636. DOI: 10.1017\/jme.2024.125.","DOI":"10.1017\/jme.2024.125"},{"key":"102284","doi-asserted-by":"crossref","unstructured":"SteelFisher GK, Blendon RJ, Brule AS, et al.: Physician emergency preparedness: A national poll of physicians. Disaster Med Public Health Prep. 2015; 9(6): 666-680. DOI: 10.1017\/dmp.2015.114.","DOI":"10.1017\/dmp.2015.114"},{"key":"102285","doi-asserted-by":"crossref","unstructured":"Lentzos F: How to protect the world from ultra-targeted biological weapons. Bull At Sci. 2020; 76(6): 302-308.","DOI":"10.1080\/00963402.2020.1846412"},{"key":"102286","doi-asserted-by":"crossref","unstructured":"Blacksell SD, Dhawan S, Kusumoto M, et al.: Laboratory-acquired infection and pathogen escapes worldwide between 2000 and 2021: A scoping review. Lancet Microbe. 2024; 5(2): e194-e202. DOI: 10.1016\/S2666-5247(23)00319-1.","DOI":"10.1016\/S2666-5247(23)00319-1"},{"key":"102287","doi-asserted-by":"crossref","unstructured":"Zavaleta-Monestel E, Rojas-Chinchilla C, Anchia-Alfaro A, et al.: Tracking the threat, 50 years of laboratory-acquired infections: A systematic review. Acta Microbiol Hell. 2025; 70(2): 11. DOI: 10.3390\/amh70020011.","DOI":"10.3390\/amh70020011"},{"key":"102288","unstructured":"Hilotin J: Laboratory leaks: Know the documented incidents of \u2018escape\u2019 of dangerous pathogens. Available at https:\/\/gulfnews.com\/special-reports\/laboratory-leaks-know-the-documented-incidentsof-escape-of-dangerous-pathogens-1.1623749030824. Accessed February 20, 2026."},{"key":"102289","doi-asserted-by":"crossref","unstructured":"Pappas G: The Lanzhou Brucella leak: The largest laboratory accident in the history of infectious diseases? Clin Infect Dis. 2022; 75(10): 1845-1847. DOI: 10.1093\/cid\/ciac463.","DOI":"10.1093\/cid\/ciac463"}],"container-title":["American Journal of Disaster Medicine"],"original-title":[],"link":[{"URL":"https:\/\/wmpllc.org\/ojs\/index.php\/ajdm\/article\/download\/4058\/4338","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/wmpllc.org\/ojs\/index.php\/ajdm\/article\/download\/4058\/4338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T19:31:30Z","timestamp":1784575890000},"score":1,"resource":{"primary":{"URL":"https:\/\/wmpllc.org\/ojs\/index.php\/ajdm\/article\/view\/4058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":83,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,7,20]]}},"URL":"https:\/\/doi.org\/10.5055\/ajdm.0527","relation":{},"ISSN":["1932-149X","1932-149X"],"issn-type":[{"value":"1932-149X","type":"electronic"},{"value":"1932-149X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}